Table 3.
Assessment of tissue expression of VEGF, TSP-1 and CD34.
| VEGF | TSP-1 | MVD (CD34) | |
| Immunostaining score | |||
| Median | 5 | 2 | 59 microvessels/mm2 |
| (range) | 2–6 | 0–3 | 16–300 |
| Expression intensity (% of cases) | |||
| Negative | 0 | 20 | |
| Weak | 0 | 30 | |
| Intermediate | 17 | 30 | |
| Strong | 83 | 20 | |